BioSpace News Archive

Biotech Beach

Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

RxSight, Inc. today announced that its Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens ® (LAL ® ), RxSight Light Delivery Device (LDD™) and accessories, will be the subject of various surgeon presentations at the annual meeting of the American Society of Cataract and Refractive Annual Meeting.

April 19, 2022
·
4 min read
Genetown

Waters Corporation to Host Investor Day

Waters Corporation (NYSE:WAT) announced today that it will host its 2022 Investor Day on Thursday, May 19, 2022, starting at 8:45 a.m. (ET) at the New York Stock Exchange, 11 Wall St, New York, NY 10005.

April 19, 2022
·
1 min read
Miravo Healthcare™ to Present at Bloom Burton & Co. Healthcare Investor Conference

Nuvo Pharmaceuticals ® Inc. today announced Jesse Ledger, Miravo’s President & Chief Executive Officer and Mary-Jane Burkett, Miravo’s Vice President & Chief Financial Officer will be presenting at the Bloom Burton & Co. Healthcare Investor Conference.

April 19, 2022
·
2 min read
Business

ImmPACT Bio Names Venkat Yepuri as Chief Operating Officer

ImmPACT Bio USA , Inc. today announced the appointment of Venkata (Venkat) P. Yepuri as chief operating officer.

April 19, 2022
·
3 min read
Biotech Bay

Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs™ in Clinical Trials

Unlearn® today announced that it has closed a $50 million Series B funding round.

April 19, 2022
·
4 min read
Pharm Country

Eyenovia Announces Poster Presentation at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting

Eyenovia, Inc. today announced that the Company will present an ePoster at the American Society of Cataract and Refractive Surgery Annual Meeting, which is being held April 23-26 in Washington, D.C.

April 19, 2022
·
5 min read
Pharm Country

gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) Selected for Department of Defense Biotech Optimized for Operational Solutions and Tactics (BOOST) Program

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore™ nVNS has been selected for further study under the United States Department of Defense Biotech Optimized for Operational Solutions and Tactics (BOOST) program.

April 19, 2022
·
6 min read
Business

Kymera Therapeutics to Report First Quarter 2022 Results and Announces Participation at Upcoming Investor Conferences

Kymera Therapeutics, Inc. today announced that the Company will report first quarter 2022 financial results on May 3rd, 2022 and will host a conference call at 8AM ET.

April 19, 2022
·
3 min read
Biotech Beach

TRACON Pharmaceuticals Announces Amended ENVASARC Protocol Approved and Open at all 30 Clinical Sites in the U.S. and U.K.

TRACON Pharmaceuticals today announced that the amended ENVASARC protocol approved by the U.S. Food and Drug Administration in February has now been approved by institutional review boards or ethics committees at all 30 clinical sites: 29 in the United States and one in the United Kingdom.

April 19, 2022
·
6 min read
Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), today announced that European Patent Office (EPO) has issued a patent providing intellectual property protection of macimorelin in 27 countries within the European Union as well as additional European non-EU countries, such as the UK and Turkey, for macimorelin (Ghryvelin®; Macrilen™) for use to diagnose growth hormone deficiency (GHD) in adults.

April 19, 2022
·
6 min read